JPMorgan Chase (JPM) may've been outbid by Vantiv for Worldpay, but there are several other mobile payment companies it could buy.

The post 3 Mobile Payment Companies JPMorgan Could Buy appeared first on InvestorPlace.

Virtual reality and augmented reality haven't taken off yet, but these three companies offer stronger pure plays than Facebook or Sony.

The post 3 Virtual Reality Stocks (That Aren’t Facebook or Sony) appeared first on InvestorPlace.

Here's a look at three biotech stocks that have at least one treatment prepped to enter pivotal clinical trials soon.

The post 3 Pivotal Drug Trials to Watch for Explosive Potential appeared first on InvestorPlace.

• 7 Healthcare Stocks That Will Give You Chest Pains

When companies look for gold in America, they do it in Nevada. These four Nevada gold mine projects could be game-changers for the gold miners carrying them out.

The post 4 Explosive Nevada Gold Mine Projects to Watch This Year appeared first on InvestorPlace.

Teva's recent migraine drug data, while positive, didn't impress investors. What happened, and should you tussle with TEVA stock?

The post Is Teva Pharmaceutical Industries Ltd (ADR) Stock a Migraine Buy? appeared first on InvestorPlace.

• 7 Stocks to Buy That Wall Street Got Dead Wrong
• 3 Stocks to Watch on Friday: Alphabet Inc (GOOGL), Workday Inc (WDAY) and Broadcom Ltd (AVGO)
• BlackBerry Ltd (BBRY) Is the Next Nvidia Corporation (NVDA). What?

Tesaro (TSRO) has already made a mint for investors thanks to a 50% spike on positive news about its ovarian cancer treatment, niraparib. What's left in the tank?

The post Tesaro Inc (TSRO): Is There More Upside for Tesaro Stock? appeared first on InvestorPlace.